Originally published In Press as doi:10.1074/jbc.M002848200 on May 19, 2000
J. Biol. Chem., Vol. 275, Issue 36, 27947-27956, September 8, 2000
The Cytosolic Termini of the
- and
-ENaC Subunits Are
Involved in the Functional Interactions between Cystic Fibrosis
Transmembrane Conductance Regulator and Epithelial Sodium
Channel*
Hong-Long
Ji
,
Michael L.
Chalfant§,
Biljana
Jovov
,
Jason P.
Lockhart
,
Suzanne B.
Parker
,
Catherine M.
Fuller
,
Bruce A.
Stanton§, and
Dale J.
Benos
¶
From the
Department of Physiology and Biophysics,
University of Alabama at Birmingham, Birmingham, Alabama 35294-0005 and
the § Department of Physiology, Dartmouth Medical School,
Hanover, New Hampshire 03755
Received for publication, April 4, 2000, and in revised form, May 2, 2000
 |
ABSTRACT |
Epithelial sodium channel (ENaC) and cystic
fibrosis transmembrane conductance regulator (CFTR) are co-localized in
the apical membrane of many epithelia. These channels are essential for
electrolyte and water secretion and/or reabsorption. In cystic fibrosis
airway epithelia, a hyperactivated epithelial Na+
conductance operates in parallel with defective Cl
secretion. Several groups have shown that CFTR down-regulates ENaC
activity, but the mechanisms and the regulation of CFTR by ENaC are
unknown. To test the hypothesis that ENaC and CFTR regulate each other,
and to identify the region(s) of ENaC involved in the interaction
between CFTR and ENaC, rENaC and its mutants were co-expressed with
CFTR in Xenopus oocytes. Whole cell macroscopic sodium
currents revealed that wild type (wt) 

-rENaC-induced Na+ current was inhibited by co-expression of CFTR, and
further inhibited when CFTR was activated with a cAMP-raising mixture
(CKT). Conversely, 

-rENaC stimulated CFTR-mediated
Cl
currents up to ~6-fold. Deletion mutations in the
intracellular tails of the three rENaC subunits suggested that the
carboxyl terminus of the
subunit was required both for the
down-regulation of ENaC by activated CFTR and the up-regulation of CFTR
by ENaC. However, both the carboxyl terminus of the
subunit and the
amino terminus of the
subunit were essential for the
down-regulation of rENaC by unstimulated CFTR. Interestingly,
down-regulation of rENaC by activated CFTR was
Cl
-dependent, while stimulation of CFTR by
rENaC was not dependent on either cytoplasmic Na+ or a
depolarized membrane potential. In summary, there appear to be at least
two different sites in ENaC involved in the intermolecular interaction
between CFTR and ENaC.
 |
INTRODUCTION |
Epithelial sodium channels
(ENaC)1 are the main pathway
for sodium absorption and routinely co-localize with CFTR in the apical membrane of many polarized epithelial cells, including airway, gastrointestinal, and renal cells (1). Studies of the pathogenesis of
cystic fibrosis in freshly isolated CF airway epithelium demonstrated that ENaC is hyperactivated in the absence of CFTR (2, 3), indicating
that CFTR may down-regulate ENaC. This idea was supported from
co-expression studies of CFTR and ENaC in Xenopus oocytes (4-6), fibroblast cells (7), and planar lipid bilayers (8-10).
Elimination of the inhibitory effect on ENaC by CFTR has been proposed
to account for the observed hyperabsorption of Na+ in the
airway and gastrointestinal epithelia of CF patients that lack
functional CFTR. The simplest explanation would be a direct physical
protein-protein interaction between CFTR and ENaC. Kunzelmann's group
(4) identified a possible protein-protein interaction between CFTR and
ENaC using the yeast two-hybrid analysis system. These authors
concluded that CFTR physically interacted with the COOH terminus of
-rENaC. However, Berdiev et al. (10) reported that CFTR
could not down-regulate channels comprised only of
-rENaC, and that
the
- and/or
-ENaC subunits were required for CFTR's functional
interaction with ENaC. Nonetheless, CFTR's ability to
down-regulate wild-type 

-rENaC was lost if
COOH-terminal-truncated
-rENaC replaced wild-type
-rENaC. In
addition, Schreiber et al. (11) found that the first
nucleotide-binding domain of CFTR was essential in the inhibition of
the epithelial sodium conductance. However, few studies have
examined the influence of ENaC on CFTR activity (12).
In the present study, truncation and missense mutations in the
cytoplasmic NH2- and COOH-terminal regions of
-,
-,
and
-rENaC subunits of rENaC were co-expressed with CFTR in
Xenopus oocytes to identify domains within ENaC that are
essential for the molecular interactions between ENaC and CFTR.
Electrophysiological studies of macroscopic currents showed that CFTR
activity is up-regulated by rENaC co-expression, and rENaC current is
inhibited by both quiescent (i.e. non-conducting) and
activated CFTR. Studies in which the cytosolic tails of rENaC subunits
were truncated demonstrated that the carboxyl terminus of the
-rENaC
subunit was required for the functional interaction between activated
CFTR and rENaC, while the amino termini of the
and
subunits
were critical for the down-regulation of rENaC by quiescent CFTR.
Therefore, at least two distinct mechanisms are involved in the
intermolecular regulation of CFTR and rENaC.
 |
MATERIALS AND METHODS |
cRNA Preparation for Oocyte Injection and Confocal
Microscopy--
The cDNA constructs of wt
-,
-, and
-rENaC cloned from rat colon and the Liddle's mutants were the kind
gifts from Drs. Cecilia Canessa and Bernard Rossier (13-16). Deletions
of the cytoplasmic NH2 termini of
-,
-, and
-rENaC
were made by PCR-based mutagenesis as described previously (17).
Enhanced green fluorescent protein (EGFP)-rENaC constructs were
prepared as described before (18). In brief, and pEGFP-
rENaC were
constructed by excising the full-length subunits from pSport/
rENaC
or pSport/
rENaC with SalI/KpnI, and ligating the excised fragment into SalI/KpnI digested
pEGFP-Cl or C2 (CLONTECH, Palo Alto, CA). Two
pre-existing stop codons in the
subunit were removed using a
synthesized sense primer corresponding to nucleotides 1-20 and an
antisense primer corresponding to nucleotides 514-543. PCR was
performed, and the product was subcloned into pCR 2.1. The fusion
cDNA EGFP rENaC was constructed by digesting the subcloned PCR
product with SalI/BsmBI and ligating the gel purified 316-base pair PCR fragment into digested cDNA.
EGFP-
-rENaC then was subcloned into pcDNA3.1 (InVitrogen) using
NheI and KpnI. pcDNA3.1 was digested with
NheI and treated with calf intestinal alkaline phosphatase
to prevent self-ligation. The sequence of both strands was confirmed by
ABI PRISM dye terminator cycle sequencing. cDNAs of full-length,
truncated, and missense mutations of rENaC were transcribed in
vitro by using T7 transcription kits (Ambion, Austin, TX),
following the manufacturer's instructions.
Two Electrode Voltage Clamp of Oocytes--
The protocol for
channel expression in oocytes was the same as described previously
(19). Briefly, female Xenopus laevis, purchased from
Xenopus Express (Burley Hill, FL), were anesthetized in 0.5% ice/tricaine (Sigma) solution. Ovary lobes were harvested through a small abdominal incision. Healthy oocytes at maturation stage
V and VI were identified following 2-3 h rotating digestion with 3 mg/ml collagenase (Roche Molecular Biochemicals, Indianapolis, IN) in
Ca2+-free OR-2 medium (in mM: 82.5 NaCl, 2.4 KCl, 1.8 MgCl2, and 5 HEPES, pH 7.4). Oocytes were
incubated in half-strength Leibovitz medium (L15) overnight before cRNA
microinjection. Using a nano-microinjector (Drummond Science Co.,
Broomall, PA), 2.5 ng of cRNA of CFTR, or 12.5 ng of cRNA of each
subunit of 

-rENaC or their combination in a volume of 50 nl,
was injected into each oocyte.
Conventional two-electrode voltage clamp was used to record the
macroscopic currents associated with rENaCs and CFTR. Oocytes were
impaled with two microelectrodes filled with 3 M KCl. The tip resistance was 0.5-2.0 M
. Oocytes were voltage clamped at a
holding potential of
30 mV using pCLAMP 6.0.4 software (Axon Instruments, Burlingame, CA) through a TEA-200 voltage clamp
amplifier (Dagan Corp., Minneapolis, MN). Two reference electrodes were connected to the bath by 3 M KCl, 3% agar bridges. Oocytes
were continuously superfused at a rate of 3 ml/min in a small holding chamber with a volume of approximately 100 µl. The normal superfusate was Ringer's solution (in mM: 110 NaCl, 2.0 KCl, 0.2 CaCl2, 1.0 MgCl2, 5.0 HEPES, pH 7.4). Both
inward and outward currents were monitored at holding potentials of
100 and +40 mV, respectively, at an interval of 10-30 s. The stepped
I-V curves were collected when the rENaC-induced currents were stable.
The perfusing system was driven by gravity, and the superfusates were
switched from Ringer's solution to those of the desired composition.
All experiments were conducted at room temperature (22 °C).
The same set of oocytes and the same batch of cRNAs were used to study
the interaction of CFTR and rENaCs. Oocytes were transferred to the
recording chamber 48 or 72 h post-cRNA injection, and superfused with Ringer's solution at room temperature. For oocytes only
expressing rENaCs, rENaC current was calculated as the
amiloride-sensitive Na+ current by subtracting the
amiloride-resistant current from the total current measured in the
absence of amiloride (10 µM). For oocytes only expressing
CFTR, the differences between the currents recorded in the absence and
in the presence of a cAMP-stimulating mixture (CKT: 0.2 mM
isobutylmethylxanthine, 0.2 mM cAMP, 10 µM forskolin) were computed as CFTR-associated Cl
currents.
For oocytes co-expressing CFTR and rENaC, the protocol we used was
first to add 10 µM amiloride to obtain the maximal rENaC
current, followed by extensive washing to remove the amiloride. Then,
oocytes were either treated with CKT or the combination of CKT and
amiloride until the total current stabilized. To test the specificity
of the interaction between CFTR and rENaCs, the endogenous
Ca2+-activated Cl
(CaCC) conductance of the
oocyte was used as a control to see if wt 

-rENaC had any
effect on its properties. A third microelectrode filled with 5 mM CaCl2 was impaled into ENaC-expressing
oocytes, and 25 nl (approximately 100 µM
CaCl2) was injected into the oocytes. Then the basal
currents for CaCC or rENaC were recorded. Conversely, the pore-forming
toxin palytoxin was employed as a substitute for rENaC to increase
intracellular Na+ concentration and depolarize the resting
membrane potential, to examine if these changes produced any effects on
CFTR.
Immunofluorescence Assay--
The protocol for fluorescence
image acquisition has been described previously (17, 20). Briefly,
healthy oocytes were injected with one group of the following cRNAs:
EGFP-CFTR; EGFP-CFTR + 

-rENaC;
-rENaC + EGFP-
-rENaC + EGFP-
-rENaC;
-rENaC + EGFP-
rENaC + EGFP-
-rENaC + CFTR. The
total injected cRNA of CFTR and 

-rENaC, the time for
processing, and the application of CKT were identical to those for the
voltage-clamp experiments. Water-injected oocytes were used as a
control for background fluorescence.
In order to identify the plasma membrane, eggs were incubated for
1 h with EZ-Link Sulfo-NHS-LC-Biotin (10 mg/ml, Pierce, Rockford,
IL). Labeling was carried out in ND-48 solution containing 10 µg/ml
Texas Red-conjugated streptavidin (Molecular Probes, Eugene, OR) in the
dark for 2 h at 4 °C with gentle agitation. The biotinylation
reaction was stopped with glycine (100 mM). After washing
in L-15 medium, images were acquired using a Leica DMIRBE TCSNT Laser
Confocal Microscope (Leica, Germany) with a 10 × dry objective,
and equipped with an acousto-optical turntable filter and three
detector channels. The 488-nm argon laser line and the 568 nm krypton
laser line excited the GFP and Texas Red, respectively. XY scans were
obtained at a 1024 × 1024 resolution format at approximately the
mid-section of each oocyte.
The distribution of EGFP-CFTR and EGFP-rENaC fluorescence present at
the membrane surface was quantitated in randomly acquired, confocal xy sections at approximately the mid-section of
each oocyte (18, 21). Using TSCNT software (Leica, Germany), a box
(~500 µm2) was drawn over the area to be
measured, and the mean pixel intensity (on a scale of 0-225) within
the boxed region was determined. Twenty sections of each oocyte
membrane were recorded and averaged for each cell. Between 5 and 10 oocytes per condition were used in the analysis. Using pixel intensity
histograms, the EGFP fluorescence and means were evaluated to determine
the relative expression of EGFP-CFTR or EGFP-rENaC before and after the
addition of CKT.
In Vitro Transcription and Translation--
cDNAs were
transcribed and translated in vitro using the TnT
transcription/translation system from Promega, in the presence of
canine pancreatic microsomes (22). The cDNAs encoding full-length, epitope-tagged
-,
-, and
-rENaC subunits are described
elsewhere (22, 23). CFTR in the pTM-1 vector was the generous gift of Dr. S. Cheng (Genzyme Corp., Cambridge, MA). The synthesized proteins were analyzed by SDS-polyacrylmide gel electrophoresis (PAGE) and
autoradiography, or reconstituted into proteoliposomes and immunoprecipitated. To test for protein-protein interactions between different rENaC subunits and CFTR, the rENaC subunits and CFTR were
translated either with radioactive methionine or with non-radioactive methionine. HA-
-rENaC and HA-
-rENaC epitope-tagged constructs were used. The same amount of each in vitro translated rENaC
subunit immunopurified and reconstituted in proteoliposomes was then
mixed with the same amount of in vitro translated CFTR
immunopurified and reconstituted in proteoliposomes, and subjected to
coprecipitation. Antibodies directed against nonlabeled protein were
used, and the presence of co-precipitated, radioactively labeled
protein was detected using autoradiography. The anti-HA and M2
antibodies were used in the following concentrations: 5 µg/ml anti-M2
antibody, 2 µg/ml anti-HA antibody. Rabbit anti-CFTR antibodies were
raised against a fusion protein corresponding to the first
nucleotide-binding domain of CFTR. All immunoprecipitations, SDS-PAGE,
and Western blots were performed as described previously (22, 23).
Chemicals--
Leibovitz-15 powdered solution, heated
inactivated horse serum, and gentamicin reagent solution were obtained
from Life Technologies, Inc. (Grand Island, NY). One-half strength L-15
medium consisted of 50% concentration of L-15, 15 mM
HEPES, 5% horse serum, and 1 mg/ml gentamycin, pH 7.5).
Amiloride (RBI, Natick, MA) was prepared as a 5 mM stock
solution in dimethyl sulfoxide/water (1:1, vol/vol). 8-Chlorophenylthio-cAMP (8-CPT-cAMP) was purchased from Roche Molecular
Biochemicals, and stocked at 200 mM in water. Forskolin, isobutylmethylxanthine, and palytoxin were from Sigma and stored in
dimethyl sulfoxide (10 and 500 mM, respectively) at
200 °C. All other reagents were from Sigma.
Statistics--
Current magnitudes were measured by using the
Clampfit program (Axon Instruments, Burlingame, CA). The means of more
than 100 data points at each voltage (episode) were acquired. The
current data recorded from different oocytes were averaged and
presented as mean ± S.E., where n stands for the
number of oocytes. Significant statistical differences between
each group were taken as p < 0.05, tested by
one-way ANOVA or paired Student's t test for parallel groups, or from data obtained from identical oocytes.
 |
RESULTS |
Expression of 

rENaC and/or CFTR, and Their
Interactions--
More than 90% of the inward current recorded in
oocytes expressing 

-rENaC was inhibited by 10 µM
amiloride, consistent with the high amiloride sensitivity of


-rENaC (Fig. 1A). The slightly inward rectified I-V curve and a reversal potential of approximately +10 mV indicated that the amiloride-sensitive current was
carried by sodium via exogenously expressed 

-rENaC (Fig. 1B). The depolarized resting membrane potential in the
oocytes expressing wt 

-rENaC resulted from the accumulated
intracellular Na+ loading that occurred during the interval
between RNA injection and current recording, and was +8.35 ± 1.05 mV (n = 78), significantly greater than that of control
oocytes injected with water (
42.5 ± 0.8 mV, n = 45, p < 0.001). In oocytes also expressing CFTR, CFTR
current could be elicited by application of a cAMP-elevating mixture
(CKT), and had a reversal potential of
25.0 ± 0.9 mV (n = 25; Fig. 1B). This resting membrane
potential was close to that of oocytes injected with water (
37.9 ± 4.1 mV, n = 30, p > 0.05). The
sensitivity of CFTR to CKT, the measured reversal potential, and the
inability of these currents to be inhibited by 100 µM
DIDS (not shown), are all features of the CFTR channel (see Ref.
24).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
Co-expression of CFTR and
  -rENaC affect sodium
and chloride currents. A, CKT inhibits the
amiloride-sensitive Na currents in oocytes co-expressing CFTR and ENaC
(+40 mV, closed circles; and 100 mV, closed
squares). B, mean I-V relationships of
amiloride-sensitive rENaC currents in (n = 22) and
CKT-activated CFTR currents in oocytes co-expressing rENaC and CFTR
(n = 25). The reversal potentials of rENaC and CFTR are
+10 and 25 mV, respectively. C, mean rENaC currents are
down-regulated in oocytes co-expressing CFTR and rENaC. CKT decreases
ENaC current. D, ENaC enhances the CFTR current (Vm
of 100 mV).
|
|
The cross-talk between currents of CFTR and 

-rENaC was
assessed from identical oocytes co-expressing CFTR and 

-rENaC, and compared with a control group expressing CFTR alone. The
amiloride-sensitive Na+ current was detected before and
during activation of CFTR with CKT, as shown in Fig. 1A.
Fig. 1C shows that rENaC current was reduced when CFTR was
present, and the significant inhibition of 

-rENaC by CFTR
could be divided into two parts. First, non-activated CFTR inhibited
ENaC current by 54% (Fig. 1C). This current was then
further reduced an additional 83% by CFTR activated by CKT (Fig.
1C). Conversely, there was a 6-fold increment in the
CFTR-mediated Cl
currents in oocytes co-expressing CFTR
and 

-rENaC (Fig. 1D). The magnitude of CFTR current
in oocytes co-expressing CFTR and 

-rENaC was
8654.2 ± 890.2 nA (n = 84), as compared with
1405.1 ± 358.2 nA in oocytes expressing CFTR alone, (n = 81).
To test the specificity of the stimulatory effect of rENaC on CFTR, the
effect of rENaC on an endogenous oocyte CaCC was examined. As
shown in Fig. 2B, this
endogenous CaCC, activated by cytosolic injection of 100 µM Ca2+ (Fig. 2A), was almost
completely suppressed in oocytes expressing rENaC (Fig. 2,
B-D). The outwardly rectified I-V relationship, with a reversal potential of about
20 mV (Fig. 2C), was
identical to that of the endogenous oocyte CaCC documented previously
(25). Because ENaC co-expression had opposite effects on CaCC as
compared with CFTR, it is unlikely that the up-regulation of CFTR by
rENaC could be due to nonspecific effects. CKT had no effect on the amiloride-sensitive current (Fig. 2E). This result is
different than that reported for rENaC following transfection into
mammalian cells (7, 26, 27), but is consistent with our (8, 28) and
others (4, 29) observations in oocytes.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 2.
rENaC inhibits CaCC current.
A, endogenous Ca2+-activated Cl
current (CaCC) in Xenopus oocytes is activated by 100 µM Ca2+, injection (in 25 nl) into the
cytoplasm. B,   -rENaC eliminated activation of
endogenous CaCC to increased cytosolic Ca2+. C,
I-V relationships show that the outwardly rectified CaCC conductance
(closed circles) has a reversal potential of approximately
20 mV. D, CaCC current at 100 mV. **, p < 0.001. E, rENaC current in the presence or absence of CKT
at a holding potential of 100 mV.
|
|
Lack of Effect of Palytoxin on CFTR and rENaC
Currents--
Overexpression of rENaC in oocytes produces an increase
in cytoplasmic sodium and a depolarization of the resting membrane potential (14, 16, 25). Thus, we tested the possibility that an
increase in intracellular Na+ concentration with a
concomitant depolarization of the membrane potential could up-regulate
CFTR currents. Oocytes expressing CFTR alone were treated with 2 nM palytoxin, a venom that mimics rENaC expression by
acting as a Na+ ionophore and inhibitor of the
Na+/K+-ATPase (30). The Na+ current
induced by palytoxin was activated gradually (Fig.
3A), and the resting membrane
potential depolarized to
1.4 ± 0.6 from
27.2 ± 5.9 mV (n = 8). In oocytes expressing CFTR
(Fig. 3B), palytoxin did not significantly affect CFTR
current (Fig. 3B). Similar results were obtained following
injection of 100 mM Na+ into CFTR-expressing
oocytes (data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 3.
Changes in intracellular sodium and membrane
voltage do not stimulate CFTR currents. A, palytoxin
(PTX) enhanced Na+ current and depolarized
the resting membrane potential (data not shown) in oocytes
expressing CFTR, but had no effect on CKT-stimulated CFTR.
B, PTX had no effect on CFTR chloride current
(Vm = 100 mV).
|
|
Is Cl
Conductance Required for CFTR Down-regulation
of ENaC?--
We next tested the hypothesis that CFTR can more
effectively down-regulate ENaC when conducting Cl
. This
was investigated by means of Cl
depletion (oocytes
incubated >l h with Cl
-free Ringer's solution as the
superfusate). As shown in Fig. 4, CFTR
inhibited the rENaC current. However, CFTR current was not inhibited
further by CKT in Cl
depleted oocytes. Therefore, we
conclude that Cl
does not have to be transported by CFTR
in order for CFTR to down-regulate ENaC.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 4.
Cl is required for
CKT-activated CFTR to inhibit ENaC. A, the sodium
current trace in an oocyte expressing   -rENaC and CFTR after
Cl depletion (incubated with Cl -free
Ringer's solution 1 h at room temperature prior to recording)
perfused with Cl -free Ringer's medium. B,
mean rENaC currents at 100 mV in Cl -depleted oocytes
with Cl -free superfusate. *, p < 0.05 compared with control.
|
|
Co-expression of Truncated and Missense Mutations of rENaC with
CFTR--
Although down-regulation of ENaC by CFTR was first reported
more than 10 years ago (see Refs. 1 and 31), the mechanisms underlying
this phenomenon are unknown. Yeast two-hybrid analysis revealed that
there was a physical protein-protein interaction between CFTR and the
COOH terminus of
-rENaC (4), but it has not been confirmed in
vivo (11) or functionally tested. Additionally, down-regulation of
rENaC by CFTR was observed in planar lipid bilayers, a cell-free model
system utilizing purified CFTR and rENaC proteins, implying that
cross-regulation of CFTR and rENaC was due to protein-protein
interaction (8, 9).
The intracellular tails of rENaC subunits contain consensus sequences
for phosphorylation (32), endocytosis (17), a PY motif for
Nedd4-regulated endocytosis (33), and sites for interaction with other
proteins such as cytoskeletal elements (34) and syntaxin (35, 36).
Similarily, most of the regulatory elements of CFTR are located in the
cytoplasmic regions, i.e. the regulatory or R domain for
phosphorylation and gating (37), the nucleotide-binding domain
(11), and the NH2 terminus for syntaxin interactions (38,
39). Therefore, to identify the amino acid regions of the cytoplasmic
termini of
-,
-, and
-rENaC subunits critical for the
intermolecular interaction of CFTR and rENaC, truncation mutants
missing the cytosolic carboxyl or NH2 termini, and missense mutations in the cytosolic carboxyl termini, were co-expressed with wt
CFTR in oocytes and the resulting Na+ and Cl
macroscopic currents examined. If the up-regulation of CFTR by ENaC was
due to a physical interaction between the carboxyl terminus of the
-rENaC subunit and CFTR (4), this up-regulation should be abolished
by the co-expression of the carboxyl terminus truncation of
-rENaC
subunit and CFTR. However, truncation of the COOH-terminal of
-rENaC
(
R613X
) did not prevent ENaC up-regulation of CFTR (Fig. 5). Likewise, a series of
NH2-terminal truncations of
-rENaC did not abolish ENaCs
stimulatory effect on CFTR, but the magnitude of CFTR up-regulation was
significantly attenuated (Fig. 5). NH2-terminal truncation
of
-rENaC, or NH2- or COOH-terminal truncation of
-rENaC had no influence on ENaCs ability to up-regulate CFTR (Fig.
5). Only COOH-terminal truncation of
-rENaC resulted in an ENaC that
failed to up-regulate CFTR activity (Fig. 5).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 5.
CFTR currents in oocytes co-expressing
truncated and missense rENaC mutants with CFTR. The normalized
CFTR currents with or without co-expression of   -rENaC and its
truncated and missense mutants. *, p < 0.05; **,
p < 0.001
|
|
Down-regulation of rENaC by CFTR was also evaluated by measuring and
comparing the amiloride-sensitive Na+ currents in oocytes
co-expressing different ENaC mutants and wt CFTR. Fig.
6A shows that, as for the
wild-type ENaC channel, macroscopic Na+ currents produced
by expression of 
2-67
-rENaC, 
2-109-
-rENaC, and
R613X-ENaC
were inhibited by both quiescent and activated CFTR, although in the
case of
R613X and 
2-109, the magnitude of the rENaC current was less, perhaps due to inefficient channel processing (Fig. 6A). Trucation of the
-rENaC
subunit (
R564X
) had no effect on the rENaC current
with or without CKT activation (Fig. 6B). However, in

Y618A
-rENaC-expressing oocytes, CFTR effectively
down-regulated the ENaC current. In contrast, the
-rENaC
NH2 terminus truncation mutant
(


2-53-rENaC) was stimulated by
CFTR co-expression, but was still down-regulated by activated CFTR
(Fig. 6C), whereas
R564X and
Y628A responded to CFTR and CFTR + mixture similarly as
did their wild-type counterparts.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
ENaC Na+ currents in oocytes
expressing CFTR and mutant ENaC. Co-expression of CFTR inhibits wt
and mutants of -rENaC (A). *, p < 0.05, but CKT application does not affect the current associated with the
COOH-terminal truncated -rENaC (B). Reversely, CFTR
co-expression up-regulates the NH2-terminal truncated
-rENaC (C).
|
|
Distribution of rENaC and CFTR--
Because cAMP regulates CFTR
trafficking to the membrane surface (5, 40, 41), and because
Nedd4-regulated endocytosis occurred through a PY-motif located in the
carboxyl terminus of the
-rENaC (33), it is possible that
down-regulation of rENaC by CFTR or up-regulation of CFTR by ENaC was
due to alterations or re-distribution of these channel proteins between
the plasma membrane and an intracellular pool. GFP, as a reporter
protein, was tagged directly onto the
- and
-rENaC subunits, or
onto CFTR directly, and visualized by confocal microscopy (Fig.
7). GFP labeling of either the
- and
-rENaC subunits or CFTR had no effect on the absolute magnitude of
either INa or ICl (data not shown). In oocytes
expressing GFP-

-rENaC, bright GFP fluorescence was seen along
the plasma membrane (Fig. 7, middle panel, rows A-D). There
was no visual or measured difference in the GFP brightness between
oocytes expressing rENaC alone (rows A and B) and
those co-expressing untagged CFTR (rows C and D).
Elevation of cytosolic cAMP level by mixture did not change the surface
expression of rENaC-GFP (row D). These results are
summarized in Table I. No green
fluorescence was observed at the oocyte surface or under the plasma
membrane in water-injected oocytes (data not shown).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Representative confocal images of oocytes
injected with EGFP-labeled rENaC only (rows A
and B) or EGFP-labeled rENaC plus CFTR
(rows C and D). Proteins in the
plasma membrane were labeled with biotin, which was detected with
streptavidin-conjugated Texas Red (images in the left
columns of all rows). GFP-labeled rENaC is shown in the
middle panels, and the overlaid images in the right
column show the co-location of GFP-rENaC. The images in rows
B and D were taken 5 min after exposing the oocytes to
CKT. The bar length represents 40 µm.
|
|
Although the mixture-induced activation of CFTR in cultured mammalian
epithelia was not due to detectable re-localization of channel proteins
from the cytosol to the surface (18), we could not rule out that the
up-regulation of CFTR by co-expressed rENaC may have resulted from an
increment in surface CFTR expression, as has been reported in other
systems including oocytes (5, 40, 41). Surface expression of GFP-CFTR
both in oocytes expressing CFTR alone (Fig.
8, rows A and B)
and co-expressing rENaC (Fig. 8, rows C and D)
was enhanced by 25-50% following addition of the cAMP-elevating
mixture (n = 5 and 10 for CFTR and CFTR + ENaC expressing oocytes, respectively). Compared with oocytes injected with
GFP-CFTR alone (Fig. 8, row A), there was a 56 ± 15%
increase in GFP-CFTR surface fluorescence in oocytes co-expressing
untagged rENaC (n = 9; Fig. 8, row C).
Addition of mixture to CFTR/ENaC expressing oocytes again produced an
additional 50% increase in CFTR surface fluorescence
(n = 10; Fig. 8, row D). Thus, while cAMP did not affect apical surface fluorescence of ENaC, it did for
CFTR (see Table I). Also, there was significantly more CFTR present at
the apical surface of oocytes co-expressing ENaC compared with
CFTR-expressing oocytes.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Representative confocal images of oocytes
injected with GFP-labeled CFTR without (rows A and
B) or with (rows C and
D) rENaC. The identical series of images as
indicated in the legend to Fig. 7 were generated. Images presented in
rows B and D were acquired 5 min post-treatment
with CKT. Experiment was repeated four times with similar
results.
|
|
Protein-Protein Interaction of CFTR and rENaC--
The
co-localization of CFTR and rENaC (Figs. 7 and 8) and the functional
identification of the carboxyl terminus of the
-ENaC subunit and the
amino terminus of
-ENaC subunit as potential domains of ENaC-CFTR
interaction, led us to investigate the hypothesis that the functional
cross-talk between these two channel proteins results from physical
interaction of CFTR and rENaC. In the first series of experiments, wt
-rENaC, containing an HA tag, or wt CFTR were in vitro
translated separately, the reaction products individually reconstituted
into proteoliposomes, and immunoprecipitated with HA or CFTR antibodies
(Fig. 9). When an HA antibody, or an anti-CFTR antibody, was used to immunoprecipitate radioactively labeled
-rENaC from the solubulized proteoliposomes, only antibodies that
recognized HA-tagged ENaC precipitated
-rENaC (see left side of Fig. 9). The first lane on each side of the figure shows an autoradiograph of the in vitro translated products of
either
-rENaC (left side) or CFTR (right
side). Thus, immunoprecipitating with an anti-CFTR antibody did
not immunoprecipitate
-rENaC. Conversely, in vitro
translated CFTR could only be immunoprecipitated by anti-CFTR
antibodies, not by the anti-HA antibody. These results demonstrate the
specificity of the antibody probes.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 9.
Analysis of
anti- -rENaC (HA) and anti-CFTR antibodies for
cross-reactivity. In order to use anti-CFTR and anti-HA
antibodies for co-immunoprecipitation, we first tested if
these antibodies were cross-reactive. The -rENaC
subunits containing the HA tag were used in these experiments.
Panel A, in vitro translated -rENaC was
subjected to immunoprecipitation using anti-HA or anti-CFTR antibodies.
Only anti-HA antibodies precipitated -rENaC, demonstrating
non-cross-reactivity of anti-CFTR antibodies with -rENaC subunit.
Panel B, in vitro translated CFTR was subjected
to immunoprecipitation using anti-CFTR or anti-HA antibodies. Only
anti-CFTR antibodies precipitated CFTR.
|
|
We next prepared proteoliposomes containing in vitro
translated radioactively labeled or non-labeled
-rENaC and CFTR, and incubated them overnight prior to coimmunoprecipitation. When anti-CFTR
antibodies were used for immunoprecipitation,
-rENaC was detected
(middle lane of left side of Fig.
10). Likewise, when the anti-HA
antibody was used, CFTR in vitro translated products were
brought down (middle lane of right side of Fig.
10). Secondary IgG antibodies did not immunoprecipitate any protein
from the proteoliposome mixture. These results show that
-rENaC and
CFTR interact in a complex within proteoliposomes made from in
vitro translated protein.

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 10.
Analysis of interaction between
-rENaC and CFTR using coprecipitation.
Panel A, the -rENaC subunit was translated in
vitro in the presence of radioactive methionine (Lane
1) and mixed with in vitro translated, nonradioactive
CFTR. Precipitation with anti-CFTR antibodies revealed co-precipitation
of -rENaC subunit. Precipitation with non-immune IgG was used
as a negative control. Panel B, CFTR was translated in
vitro in the presence of radioactive methionine (Lane
1) and mixed with in vitro translated
nonradioactive -rENaC (HA-tagged). Precipitation from this
mixture with non-immune IgG was used as a negative control.
Precipitation with anti- -rENaC antibodies (HA) revealed
co-precipitation of CFTR.
|
|
Following the same protocol, we performed co-immunoprecipitation
experiments from combinations of different in vitro
translated rENaC subunits and truncated constructs and CFTR. The
results of these immunoprecipitation experiments are summarized
in Table II. Wild type
- and
-rENaC
can be co-immunoprecipitated with CFTR, whereas the wild
type
-rENaC subunit cannot. A COOH-terminal truncated
-rENaC or
-rENaC can also be co-immunoprecipitated with CFTR. However,
NH2-terminal deletions of
-rENaC or
-rENaC cannot.
These results suggest that the NH2 termini of the
- and
-rENaC subunits are sites of contact for protein-protein interaction between rENaC and CFTR.
View this table:
[in this window]
[in a new window]
|
Table II
Co-immunoprecipitation of in vitro translated rENaC subunits and
CFTR
Each co-immunoprecipitation experiment was performed a minimum of three
times. Anti-CFTR antibodies were used to co-immunoprecipitate ENaC.
|
|
 |
DISCUSSION |
The hyperabsorption of sodium in native CF airway and intestinal
epithelia and in cultured renal A6 cells is closely paralleled by the
lack of functional CFTR (1, 42, 43). Evidence obtained from
heterologous systems, amiloride inhibitable transepithelial electrical
potentials, and in short circuit current measurements is consistent
with the interpretation that CFTR can down-regulate ENaC. However, the
mechanisms underlying the down-regulation of ENaC by CFTR remain
unknown. Although noted by some laboratories (5, 12), activation by
ENaC of CFTR currents have largely been neglected. Accordingly, human
CFTR and rENaC were co-expressed in Xenopus oocytes to
determine the functional relationships between them. Inhibition of
rENaC was produced not only by activated CFTR, consistent with the
observations of other groups (5, 6, 11, 29, 44), but also rENaC
reversibly facilitated cAMP-dependent CFTR activation.
The major finding reported in this work is that there is a coordinate
influence of CFTR on ENaC and rENaC on CFTR when heterologously expressed in Xenopus oocytes. While CFTR can down-regulate
ENaC activity, ENaC can stimulate the activity of CFTR up to 6-fold. We
show that this up-regulation of CFTR by ENaC is produced in part by an
increase in surface density of CFTR. We found that the carboxyl
terminus of the
-rENaC subunit was involved in both the
down-regulation of ENaC by CFTR and the up-regulation of CFTR by ENaC.
However, both the carboxyl terminus of
-rENaC and the amino terminus
of r-rENaC were essential for CFTR to down-regulate ENaC.
Co-immunoprecipitation experiments revealed a biochemical interaction
between ENaC and CFTR, but no clear correlation between the regions of
biochemical interaction and functional interaction emerged.
The proposed intracellular regulatory fragments of CFTR are in the
first nucleotide-binding domain (NBD1) (11). Mutation of NBD1 abolishes
the inhibitory effects of CFTR on ENaC co-expressed in oocytes. We
therefore performed mutagenesis studies on rENaC to locate the
subunit(s) that might mediate this effect. The electrophysiological results revealed that the cytoplasmic carboxyl terminus of the
subunit is closely linked to the intermolecular regulation between rENaC and activated CFTR. Furthermore, the corresponding subunit for
the interaction of non-activated CFTR and rENaC might be mediated by
the cytoplasmic NH2 terminus of
subunit and the
carboxyl terminus of
subunit. Additionally, the observation that
rENaC down-regulated the activity of an endogenous CaCC of the oocyte confirmed the specificity of the interaction between ENaC and CFTR. The
loss of the down-regulation of rENaC by cAMP-activated CFTR following
intraoocyte Cl
depletion implied a requirement for
Cl
. The lack of response of rENaC expressed in oocytes to
cAMP was different from that observed in transfected mammalian cells
(7, 26).
The observation that there was little or no inhibition of CFTR with
increasing [Na+]i and decreasing
Vm with palytoxin demonstrated a lack of effect of
[Na+]i and Vm on CFTR
activity. Combined with the results of intracellular Na+
injection, we conclude that the up-regulation of CFTR by ENaC was not
due to increased cytoplasmic Na+ or a depolarized membrane
potential. The equivalent stimulation of CFTR by the Liddle's mutants
(
Y618A
, 

Y628A, and


R574X), which produce a constitutively activated
Na+ conductance, and the NH2-terminal
-mutant (
2-109
), which has
undetectable current, also support the conclusion that elevated
[Na+]i and depolarization failed to activate
CFTR. Even though there was a greater than 2-fold enhancement of
surface fluorescence of GFP-labeled CFTR in oocytes co-expressing ENaC
(Fig. 8), and if this could be translated into a 2-3-fold increase in
number of CFTR channels at the surface, this is not enough to account for the greater than 4-fold increase in macroscopic current measured under these conditions (Fig. 10). Moreover, the lack of a correlation between mRNA, conductance of CFTR, and severity of disease (44) supports the hypothesis that the ENaC influences CFTR in ways other
than simply increasing CFTR number. This model is not unique and has
been used to interpret the constitutively activated Na+
conductance in Liddle's syndrome (46, 47). Electrophysiological recording further suggested that CFTR channel number per patch and the
mean open time were increased in oocytes co-expressing rENaC (48). The
potential pathophysiololgical relevance of ENaC's ability to activate
CFTR remains to be determined in vivo.
Functional coupling of inhibition of rENaC with stimulation of CFTR
suggests that cAMP-dependent protein kinase phosphorylation could be involved in the interaction between two channels. The effects
of cAMP (26, 32), and actin (49) on ENaC and CFTR predicts that the
functional activation of CFTR by phosphorylation is critical for the
secondary inactivation of ENaC by activated CFTR. Whether or not this
cAMP-regulated system requires the presence of associated proteins
binding to both channels is unknown. Associated proteins with possible
regulatory functions include the syntaxin family (35, 36), G proteins
(8), cAMP-response element-binding protein (50), and NHERF (51).
It is also conceivable that protein kinase C, which regulates both CFTR
and ENaC, might be involved in the cross-talk because protein kinase C
regulatory sites are located in the carboxyl terminus of
-ENaC and
the intracellular R domain of CFTR (52). It is presently unclear
whether or not the up-regulation of CFTR by ENaC controlled via the
same signaling pathway.
Because there is a PY domain in the carboxyl terminus of each ENaC
subunit, it is possible that Nedd4-regulated internalization (33) could
contribute to the down-regulation of ENaC activity by CFTR. But an
increment in the surface channel density of ENaC was not evident in
oocytes not co-expressing CFTR (Fig. 7). Moreover, these confocal
imaging experiments are consistent with the earlier patch-clamp
experiments of Stutts et al. (26) who reported that co-expression of CFTR with ENaC in mouse fibroblasts did not change the
average channel number of ENaC observed per patch. Therefore, it is
unlikely that CFTR influences ENaC activity by modulating endocytosis
through Nedd4. Overexpression of CFTR would bring about multiple
alterations in oocytes (for example, endogenous K channel activation),
and further experiments need to be undertaken to explore the mechanisms
of CFTR and ENaC interaction.
Co-immunoprecipitation experiments showed that COOH-terminal deleted
-rENaC could interact with CFTR, and that
-rENaC, when expressed
without its
- and
-rENaC partners, could not (Table II). The lack
of concordance between the functional and biochemical studies
concerning the subunit domains of ENaC involved in the interactions
between CFTR and ENaC reveal the complexity of these interactions. This
complexity is underscored by the observation that in human sweat ducts,
ENaC activity increases rather than decreases in the presence of CFTR
(53). While the functional data suggest that the carboxyl terminus of
the
-ENaC subunit and amino terminus of the
-ENaC subunit are
potential domains of ENaC-CFTR interaction, co-immunoprecipitation
results suggest that NH2 termini of
- and
-rENaC are
involved in this interaction as well. However, there are several
differences in experimental conditions for functional expression in
oocytes and for in vitro coprecipitation. Oocyte expression
was performed expressing all three rENaC subunits and CFTR
simultaneously, permitting oligomerization of rENaC subunits (see Refs.
54 and 55). Co-precipitation experiments tested the interaction between
each individual ENaC subunit and CFTR separately. Immunoprecipitation
experiments in oocytes proved to be difficult, even using
epitope-tagged ENaC constructs, undoubtedly due to relatively low
expression levels. Moreover, functional studies in oocytes can include
other intermediate proteins in ENaC-CFTR interaction, such as those
interacting with PDZ domains or cytoskeletal elements (56-58). Thus,
our results suggest that there may be "tethering" domains that hold
the channels together so that other "regulatory" domains can interact.
In conclusion, co-expression of CFTR and rENaC in Xenopus
oocytes, and the up-regulation of CFTR activity was
associated closely with a decrease in parallel in ENaC conductance. The
cytoplasmic carboxyl terminus of the
-ENaC subunit appears to be
required for the functional cross-talk between ENaC and CFTR, and the
cytosolic amino termini of both the
- and
-ENaC subunits are
essential for the down-regulation of ENaC by CFTR co-expression.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Albert Tousson (Cell Biology,
University of Alabama) and Dr. Anne Lynn Langloh for their kind help in
using confocal microscope, and Dr. Pierre-Jean Ripoll for making the
HA-tagged ENaC subunit constructs. We also thank Dr. Thomas R. Kleyman
for providing access to his unpublished work. We thank Cathy Guy and Elaine Dean for providing excellent administrative support. We greatly
appreciate the discussions with Dr. Ernest M. Wright (Physiology, UCLA)
and Jian Fu (Physiology, University of Alabama).
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK45881, DK51067, DK53090 and the Cystic Fibrosis Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Physiology and Biophysics, University of Alabama at Birmingham, 1918 University Blvd., MCLM 704, Birmingham, AL 35294-0005. Tel.:
205-934-6220; Fax: 205-934-1445;
E-mail:Benos@physiology.uab.edu.
Published, JBC Papers in Press, May 19, 2000, DOI 10.1074/jbc.M002848200
 |
ABBREVIATIONS |
The abbreviations used are:
ENaC, epithelial
sodium channel;
CF, cystic fibrosis;
CFTR, cystic fibrosis
transmembrane conductance regulator;
CKT, cAMP-stimulating mixture;
CaCC, calcium-activated chloride channel;
GFP, green fluorescent
protein;
DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid;
PCR, polymerase chain reaction;
HA, hemagglutinin;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
| 1.
|
Schwiebert, E. M.,
Benos, D. J.,
Egan, M. E.,
Stutts, M. J.,
and Guggino, W. B.
(1999)
Physiol. Rev.
79,
S145-S166
|
| 2.
|
Mall, M.,
Bleich, M.,
Greger, R.,
Schreiber, R.,
and Kunzelmann, K.
(1998)
J. Clin. Invest.
102,
15-21
|
| 3.
|
Kunzelmann, K.,
Kathofer, S.,
and Greger, R.
(1995)
Pflugers Arch.
431,
1-9
|
| 4.
|
Kunzelmann, K.,
Kiser, G. L.,
Schreiber, R.,
and Riordan, J. R.
(1997)
FEBS Lett.
400,
341-344
|
| 5.
|
Briel, M.,
Greger, R.,
and Kunzelmann, K.
(1998)
J. Physiol. (Lond.)
508,
825-836
|
| 6.
|
Hopf, A.,
Schreiber, R.,
Mall, M.,
Greger, R.,
and Kunzelmann, K.
(1999)
J. Biol. Chem.
274,
13894-13899
|
| 7.
|
Stutts, M. J.,
Canessa, C. M.,
Olsen, J. C.,
Hamrick, M.,
Cohn, J. A.,
Rossier, B. C.,
and Boucher, R. C.
(1995)
Science
269,
847-850
|
| 8.
|
Ismailov, I. I.,
Awayda, M. S.,
Jovov, B.,
Berdiev, B. K.,
Fuller, C. M.,
Dedman, J. R.,
Kaetzel, M.,
and Benos, D. J.
(1996)
J. Biol. Chem.
271,
4725-4732
|
| 9.
|
Ismailov, I. I.,
Berdiev, B. K.,
Shlyonsky, V-G.,
Fuller, C. M.,
Prat, A. G.,
Jovov, B.,
Cantiello, H. F.,
Ausiello, D. A.,
and Benos, D. J.
(1997)
Am. J. Physiol. Cell Physiol.
272,
C1077-C1086
|
| 10.
|
Berdiev, B. K.,
Shlyonsky, V. G.,
Karlson, K. H.,
Stanton, B. A.,
and Ismailov, I. I.
(2000)
Biophys. J.
78,
1881-1894
|
| 11.
|
Schreiber, R.,
Hopf, A.,
Mall, M.,
Greger, R.,
and Kunzelmann, K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
5310-5315
|
| 12.
|
Jiang, Q.,
Li, J.,
Dubroff, R.,
Ahn, Y. J.,
Foskett, K.,
Engelhardt, J.,
and Kleyman, T. R.
(2000)
J. Biol. Chem.
275,
13266-13274
|
| 13.
|
Canessa, C. M.,
Horisberger, J. D.,
and Rossier, B. C.
(1993)
Nature
361,
467-470
|
| 14.
|
Canessa, C. M.,
Schild, L.,
Buell, G.,
Thorens, B.,
Gautschi, I.,
Horisberger, J. D.,
and Rossier, B. C.
(1994)
Nature
367,
463-467
|
| 15.
|
Schild, L.,
Canessa, C. M.,
Shimkets, R. A.,
Gautschi, I.,
Lifton, R. P.,
and Rossier, B. C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5699-5703
|
| 16.
|
Schild, L.,
Schneeberger, E.,
Gautschi, I.,
and Firsov, D.
(1997)
J. Gen. Physiol
109,
15-26
|
| 17.
|
Chalfant, M. L.,
Denton, J. S.,
Langloh, A. L.,
Karlson, K. H.,
Loffing, J.,
Benos, D. J.,
and Stanton, B. A.
(1999)
J. Biol. Chem.
274,
32889-32896
|
| 18.
|
Moyer, B. D.,
Loffing, J.,
Schwiebert, E. M.,
Loffing-Cueni, D.,
Halpin, P. A.,
Karlson, K. H.,
Ismailov, I. I.,
Guggino, W. B.,
Langford, G. M.,
and Stanton, B. A.
(1998)
J. Biol. Chem.
273,
21759-21768
|
| 19.
|
Ji, H. L.,
Fuller, C. M.,
and Benos, D. J.
(1998)
Am. J. Physiol.
275,
C1182-C1190
|
| 20.
|
Langloh, A. L.,
Berdiev, B.,
Ji, H. L.,
Keyser, K.,
Stanton, B. A.,
and Benos, D. J.
(2000)
Am. J. Physiol. Cell Physiol.
278,
C277-C291
|
| 21.
|
Gottardi, C. J.,
and Caplan, M. J.
(1993)
J. Cell Biol.
121,
283-293
|
| 22.
|
Jovov, B.,
Tousson, A.,
Ji, H. L.,
Keeton, D.,
Shlyonsky, V.,
Ripoll, P. J.,
Fuller, C. M.,
and Benos, D. J.
(1999)
J. Biol. Chem.
274,
37845-37854
|
| 23.
|
Jovov, B.,
Shlyonsky, V. G.,
Berdiev, B. K.,
Ismailov, I. I.,
and Benos, D. J.
(1998)
Am. J. Physiol.
275,
C449-C458
|
| 24.
|
Fuller, C. M.,
and Benos, D. J.
(1992)
Am. J. Physiol
263,
C267-C286
|
| 25.
|
Ji, H. L.,
DuVall, M. D.,
Patton, H. K.,
Satterfield, C. L.,
Fuller, C. M.,
and Benos, D. J.
(1998)
Am. J. Physiol.
274,
C455-C464
|
| 26.
|
Stutts, M. J.,
Rossier, B. C.,
and Boucher, R. C.
(1997)
J. Biol. Chem.
272,
14037-14040
|
| 27.
|
Letz, B.,
and Korbmacher, C.
(1997)
Am. J. Physiol. Cell Physiol.
272,
C657-C666
|
| 28.
|